Polaris Wealth Advisory Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-329,178
Closed -$42.8M 179
2022
Q1
$42.8M Buy
+329,178
New +$39.7M 2.86% 3
2018
Q4
Sell
-625
Closed -$80K 482
2018
Q3
$80K Buy
625
+493
+373% +$58.6K 0.01% 217
2018
Q2
$14K Sell
132
-493
-79% -$53.7K ﹤0.01% 189
2018
Q1
$66K Buy
+625
New +$72.6K 0.01% 201
2016
Q4
Sell
-4,465
Closed -$564K 132
2016
Q3
$564K Sell
4,465
-220
-5% -$27.2K 0.07% 79
2016
Q2
$548K Buy
4,685
+142
+3% +$16.1K 0.09% 64
2016
Q1
$470K Buy
+4,543
New +$439K 0.07% 71

Other funds holding ZBH

Polaris Wealth Advisory Group's ZBH Position: Q2 2022 in Review

Polaris Wealth Advisory Group sold out of Zimmer Biomet (ZBH) in Q2 2022, closing a stake of 329,178 shares — an estimated $42.8M sold.

Polaris Wealth Advisory Group first reported a position in ZBH in Q1 2016 and held it in 7 quarters. The position peaked at $42.8M in Q1 2022. 957 funds tracked by Wall St. Rank hold ZBH as of Q2 2022.

  • Polaris Wealth Advisory Group reported no remaining Zimmer Biomet position as of Q2 2022 after selling out during the quarter.
  • Polaris Wealth Advisory Group sold 329,178 Zimmer Biomet shares in Q2 2022, an estimated $42.8M.
  • Polaris Wealth Advisory Group first reported a position in Zimmer Biomet in Q1 2016 and held it in 7 quarters.
  • Polaris Wealth Advisory Group's Zimmer Biomet position peaked at $42.8M in Q1 2022.
  • 957 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2022.

Based on Polaris Wealth Advisory Group's 13F filing for Q2 2022, filed 12 Jul 2022.